Cerespectus is developing a catheter delivery system for targeted gene therapy administration in the central nervous system. Its integrated camera provides real-time anatomical visualization, enabling precise catheter placement in the subarachnoid space to improve therapeutic efficacy for CNS disorders.
Funding
Funding not disclosed
Founders
Product
Problem
Treating central nervous system (CNS) disorders with gene therapy faces challenges in achieving precise and targeted delivery to specific anatomical spaces like the subarachnoid space. Inaccurate catheter placement can lead to suboptimal therapeutic efficacy and potential off-target effects.
Solution
Cerespectus is developing an advanced catheter delivery system designed for targeted gene therapy administration within the central nervous system. This system incorporates a multi-lumen catheter equipped with an integrated camera, providing real-time visualization of brain and spine anatomy during the procedure. By leveraging techniques from interventional neuroradiology and endovascular neurosurgery, the technology aims to enable more physicians to achieve accurate catheter placement, thereby improving therapeutic delivery and patient outcomes for CNS-related diseases. The system is engineered for scalability and ease of use, facilitating broader adoption in clinical practice.
Target Audience
The primary target audience includes neurosurgeons, interventional neuroradiologists, and medical device distributors specializing in neurological therapies.
Features
- Multi-lumen catheter design for simultaneous delivery and visualization
- Integrated camera system for real-time anatomical imaging during placement
- Subarachnoid space targeting capability for precise gene therapy delivery
- Engineered for trackability and maneuverability within complex neurovasculature
- Scalable design principles derived from interventional neuroradiology practices
- Focus on enhancing precision and ease of use for proceduralists